There is no FDA-approved product designed to optimize the vascular access site before needle insertion. We intend to define and lead this category.
Vascular access is one of the most common procedures in medicine, performed hundreds of millions of times annually worldwide, yet no dedicated site preparation product exists.
Global vascular access device and preparation market across all access types and clinical settings.
Interventional radial access and high-value vascular access procedures in the US and EU where site optimization has the greatest clinical impact.
Achievable at approximately 5% penetration of the interventional cardiology radial access segment alone.
Multiple macro trends in interventional medicine are expanding the addressable market and increasing the urgency for better access site solutions.
Vascular access procedures performed globally each year, spanning cardiac catheterization, IV placement, dialysis, and interventional radiology.
Interventional cardiology has shifted decisively toward radial access due to lower bleeding and complication rates, but radial spasm remains a barrier.
Up to one in four transradial procedures is complicated by radial artery spasm, driving procedural failures, crossovers, and patient discomfort.
Existing products address only part of the problem and were not designed for the vascular access use case.
| Approach | Local Anesthesia | Vasodilation | Non-Invasive | Pre-Procedural | Purpose-Built |
|---|---|---|---|---|---|
| Subcutaneous Lidocaine | ✓ | ✗ | ✗ | ✓ | ✗ |
| EMLA Cream | ~ | ✗ | ✓ | ✗ 60+ min | ✗ |
| Intra-arterial Cocktails | ✗ | ✓ | ✗ | ✗ | ✗ |
| Nitroglycerin Patch | ✗ | ~ | ✓ | ✓ | ✗ |
| Enso Vascular Patch | ✓ | ✓ | ✓ | ✓ | ✓ |
A single-use consumable with strong unit economics, positioned for rapid adoption in a procedure that is already being performed.
Topical patch format with established manufacturing processes enables gross margins consistent with specialty pharmaceutical products.
Integrates into existing workflows. Clinicians already prepare the access site; the Enso Patch simply replaces an inferior approach with a better one.
Vascular access is universal across healthcare systems worldwide. The radial-first trend is accelerating in every major market.
Initial indication in transradial catheterization, with a clear path to expand into IV access, dialysis, and other vascular access applications.
Medical device companies that defined new procedural categories in interventional cardiology have generated significant value. The vascular access site preparation category represents a similar greenfield opportunity with large procedure volumes, clear unmet clinical need, and no incumbent product to displace.
Analogous category-defining products in adjacent procedural spaces have supported valuations of $200M+ at acquisition, even with limited commercial traction, based on the strength of clinical data and market positioning.
First-mover in a new category with provisional IP protection and a clear development path
Well-characterized ingredients reduce regulatory risk and accelerate time to market
Massive procedure volume supports rapid revenue scaling at even modest penetration rates
Platform potential across multiple vascular access indications multiplies the addressable opportunity